ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Par Drugs & Chemicals Ltd submitted a SEBI Regulation 74(5) compliance certificate for the quarter ended June 30, 2026. The filing confirms dematerialisation of securities with MUFG Intime India.
Par Drugs and Chemicals secured a rectification order deleting a tax demand of ₹0.20 Crore. The demand is now nil, with no material financial impact.
Par Drugs and Chemicals received a rectification order deleting a prior income tax demand. The demand is now nil, with no financial impact.
Par Drugs received a ₹0.20 Crore income tax demand due to clerical errors. Management expects the demand to be recomputed to nil following rectification.